Australia markets close in 57 minutes

Context Therapeutics Inc. (CNTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5400+0.1000 (+6.94%)
At close: 03:59PM EDT
1.5900 +0.05 (+3.25%)
After hours: 07:42PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 22.99M
Enterprise value -22.61M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.51
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-69.80%
S&P500 52-week change 3-6.14%
52-week high 310.8700
52-week low 31.2700
50-day moving average 31.8374
200-day moving average 33.0169

Share statistics

Avg vol (3-month) 3288.77k
Avg vol (10-day) 3171.12k
Shares outstanding 515.97M
Implied shares outstanding 6N/A
Float 89.17M
% held by insiders 110.46%
% held by institutions 125.24%
Shares short (28 Apr 2022) 414.06k
Short ratio (28 Apr 2022) 40.03
Short % of float (28 Apr 2022) 40.09%
Short % of shares outstanding (28 Apr 2022) 40.09%
Shares short (prior month 30 Mar 2022) 468.05k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-25.47%
Return on equity (ttm)-58.77%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-13M
Diluted EPS (ttm)-1.9410
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)45.73M
Total cash per share (mrq)2.86
Total debt (mrq)123.58k
Total debt/equity (mrq)0.27
Current ratio (mrq)29.16
Book value per share (mrq)2.84

Cash flow statement

Operating cash flow (ttm)-10.9M
Levered free cash flow (ttm)-8.9M